1. Shimi G, Sohouli MH, Ghorbani A, Shakery A, Zand H. The interplay between obesity, immunosenescence, and insulin resistance. Immunity & Ageing. 2024;21(1):13
. http://doi.org/10.1186/s12979-024-00414-7
2. Nguyen L, Shanmugan S. A Review Article: The relationship between obesity and colorectal cancer. Current Diabetes Reports. 2025;25(1):8. http://doi.org/10.1007/s11892-024-01556-0
3. Schulze MB, Stefan N. Metabolically healthy obesity: from epidemiology and mechanisms to clinical implications. Nature Reviews Endocrinology. 2024;20(11):633-46
. http://doi.org/10.1016/S2213-8587(13)70062-7
4. Arneth B. Mechanisms of Insulin Resistance in Patients with Obesity. Endocrines. 2024;5(2):153-65.
https://doi.org/10.3390/endocrines5020011
5. Alcalá M, Calderon-Dominguez M, Serra D, Herrero L, Viana M. Mechanisms of impaired brown adipose tissue recruitment in obesity. Frontiers in Physiology. 2019;10:94
. https://doi.org/10.3389/fphys.2019.00094
6. Peres Valgas da Silva C
, Hernández-Saavedra D, White JD, Stanford KI. Cold and exercise: therapeutic tools to activate brown adipose tissue and combat obesity. Biology. 2019;8(1):9
. https://doi.org/10.3390/biology8010009
7. Sims NA, Lévesque J-P. Oncostatin M: dual regulator of the skeletal and hematopoietic systems. Current Osteoporosis Reports. 2024;22(1):80-95
. https://doi.org/10.1007/s11914-023-00837-z
8. Pellitero S, Piquer-Garcia I, Ferrer-Curriu G, Puig R, Martínez E, Moreno P, et al. Opposite changes in meteorin-like and oncostatin m levels are associated with metabolic improvements after bariatric surgery. International Journal of Obesity. 2018;42(4):919-22
. https://doi.org/10.1038/ijo.2017.268
9. Atakan MM, Koşar ŞN, Güzel Y, Tin HT, Yan X. The role of exercise, diet, and cytokines in preventing obesity and improving adipose tissue. Nutrients. 2021;13(5):1459
. https://doi.org/10.3390/nu13051459
10. Soldavini J. Krause's food & the nutrition care process. Journal of Nutrition Education and Behavior. 2019;51(10):1225
. https://doi.org/10.1016/j.jneb.2019.06.022
11. Armstrong A, Jungbluth Rodriguez K, Sabag A, Mavros Y, Parker HM, Keating SE, Johnson NA. Effect of aerobic exercise on waist circumference in adults with overweight or obesity: a systematic review and meta‐analysis. Obesity Reviews. 2022;23(8):e13446
. https://doi.org/10.1111/obr.13446
12. Jamshidi Rad F, Nikoofar M, Nayebifar S. Effectiveness of eight weeks aerobic training and nano curcumin supplementation on serum amyloid a protein content and body composition in overweight and obese women. North Khorasan University of Medical Sciences. 2020;12(2):1-8.
http://dx.doi.org/10.52547/nkums.12.2.1
13. Ramezani Z, Hejazi SM, Rashidlamir A. Effect of eight weeks aerobic exercise and green tea on atherogenic ratio and ABCG8 gene expression of PBMC globules in overweight women. Iranian Journal of Diabetes and Obesity. 2018;10(3):130-6
. Available at:
https://ijdo.ssu.ac.ir/article-1-428-en.html
14. Sánchez‐Infantes D, Cereijo R, Peyrou M, Piquer‐Garcia I, Stephens JM, Villarroya F. Oncostatin m impairs brown adipose tissue thermogenic function and the browning of subcutaneous white adipose tissue. Obesity
.2017; 25 (1): 85-93
. https://doi.org/10.1002/oby.21679
15. Bailey JL, Hang H, Boudreau A, Elks CM. Oncostatin M induces lipolysis and suppresses insulin response in 3T3-L1 adipocytes. International Journal of Molecular Sciences. 2022;23(9):4689
. https://doi.org/10.3390/ijms23094689
16. Macedo M, Silva A, Olher R, Coelho-Junior H, Palmeira R, Asano RY. Post-exercise hypotension between different protocols of resistance training for beginners. J Exercise Physiol. 2014;17(6):58-66. Available at:
https://www.asep.org/asep/asep/JEPonlineDECEMBER2014_Asano.pdf
17. Beam WC, Adams GM. Exercise physiology: McGraw-Hill; 2011
.
18. Johnson R, McNutt P, MacMahon S, Robson R. Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis. Clinical chemistry. 1997;43(11):2183-4
. https://doi.org/10.1093/clinchem/43.11.2183
19. Matthews DR, Hosker JP, Rudenski AS
, Naylor B, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9
. https://doi.org/10.1007/BF00280883
20. King N, Caudwell P, Hopkins M, Byrne N, Colley R, Hills A. & Blundell, JE (2007). Metabolic and behavioral compensatory responses to exercise interventions: barriers to weight loss. Obesity (Silver Spring, Md).15(6):1373-83
. https://doi.org/10.1038/oby.2007.164
21. Pourrahim Ghouroghchi A, Ghayyem Alaee N, Anoushiravani S. The effect of eight weeks of aerobic-yoga training on serum Irisin level, lipid profile and body composition of obese women. Metabolism and Exercise. 2021;11(1):59-73
. https://doi.org/10.22124/jme.2022.21981.228
22. Jones TE, Basilio J, Brophy P, McCammon M, Hickner R. Long‐term exercise training in overweight adolescents improves plasma peptide YY and resistin. Obesity. 2009;17(6):1189-95
. https://doi.org/10.1038/oby.2009.11
23. Kumar AS, Maiya AG, Shastry B, Vaishali K, Ravishankar N, Hazari A, et al. Exercise and insulin resistance in type 2 diabetes mellitus: a systematic review and meta-analysis. Annals of physical and rehabilitation medicine. 2019;62(2):98-103
. https://doi.org/10.1016/j.rehab.2018.11.001
24. Vaezi P, Zolfaghari MR, Toloueiazar J. Effects of 8 weeks aerobic training on serum level of CTRP9, omentin-1, lipid profile and insulin resistance in inactive obese woman. Journal of Applied Health Studies in Sport Physiology. 2018;5(1):45-52
. https://doi.org/10.25122/jml-2018-0033
25. Stanford KI, Goodyear LJ. Exercise regulation of adipose tissue. Adipocyte. 2016;5(2):153-62
. https://doi.org/10.1080/21623945.2016.1191307
26. Cheng L, Wang J, Dai H, Duan Y, An Y, Shi L, et al. Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus. Adipocyte. 2021;10(1):48-65
. https://doi.org/10.1080/21623945.2020.1870060
27. Komori T, Tanaka M, Furuta H, Akamizu T, Miyajima A, Morikawa Y. Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice. Diabetologia. 2015;58:1868-76
. https://doi.org/10.1007/s00125-015-3613-9
28. Masjedi A, Hajizadeh F, Dargani FB, Beyzai B, Aksoun M, Hojjat-Farsangi M, et al. Oncostatin M: a mysterious cytokine in cancers. International Immunopharmacology. 2021;90:107158
. https://doi.org/10.1016/j.intimp.2020.107158
29. Akarsu M, Hurşitoğlu M, Toprak Z, Yoldemir ŞA, Altun Ö, Toprak ID, et al. Relationships among oncostatin M, insulin resistance, and chronic inflammation: a pilot study. Archives of Endocrinology and Metabolism. 2019;64:38-44.
https://doi.org/10.20945/2359-3997000000176
30. Piquer-Garcia I, Campderros L, Taxerås SD, Gavaldà-Navarro A, Pardo R, Vila M, et al. A role for oncostatin M in the impairment of glucose homeostasis in obesity. The Journal of Clinical Endocrinology & Metabolism. 2020;105(3):e337-e48
. https://doi.org/10.1210/clinem/dgz090
31. van Krieken P, Odermatt T, Blueher M, Wueest S, Konrad D, editors. Oncostatin M inhibits browning of white adipose tissue via gp130 signalling. Diabetologia; 2020: Springer One New York Plaza, Suite 4600, New York, Ny, United States. https://doi.org/10.1016/j.molmet.2021.101341
